Test characteristics of various screening modalities for cervical cancer: A feasibility study to develop an alternative strategy for resource-limited settings

Cytopathology

Volumn 17, Issue 6, 2006, Pages 348-352

  Sodhani, P ^a,b   Gupta, S ^a   Sharma, J K ^a   Parashari, A ^a   Halder, K ^a   Singh, V ^a   Sehgal, A ^a  

^a INSTITUTE OF CYTOLOGY AND PREVENTIVE ONCOLOGY   (India)

^b 201 Mavilla Apartments ^*  (India)

Author keywords

Cancer; Cervical screening; Cervix; Cytodiagnosis; Cytological techniques; Cytology; Diagnosis; Laboratory diagnosis; Papanicolaou smear; Screening; Visual inspection

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CANCER SCREENING; CYTOLOGY; DIAGNOSTIC PROCEDURE; DNA DETERMINATION; FEASIBILITY STUDY; FEMALE; GOLD STANDARD; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MASS SCREENING; PARAMETER; PRECANCER; PREDICTION AND FORECASTING; PREDICTIVE VALIDITY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SQUAMOUS EPITHELIUM; STATISTICAL ANALYSIS; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VISUAL INSPECTION WITH ACETIC ACID APPLICATION; VISUAL INSPECTION WITH ACETIC ACID APPLICATION AND MAGNIFICATION; WART VIRUS;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEASIBILITY STUDIES; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 33751322707     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/j.1365-2303.2006.00351.x     Document Type: Article

References (23)

1. Koss LG. The Papanicolaou test for cervical cancer detection: a triumph and a tragedy. JAMA 1989;261:737-43.
2. Lee KR, Munna EA, St John T. Atypical endocervical glandular cells: accuracy of cytologic diagnosis. Diagn Cytopathol 1995;13:202-8.
3. Ylitalo N, Sorenson P, Josefsson AM et al. Consistent high viral load of human papilloma virus 16 and risk of cervical carcinoma in situ: a nested case control study. Lancet 2000;355:2194-8.
4. Cuzick J, Jerry G, Ho L, Hollongworth T, Anderson M. Type specific humanpapilloma virus DNA in abnormal smear as a predictor of high grade cervical intraepithelial neoplasia. Br J Cancer 1994;69:167-71.
5. Gaarenstroom KN, Melkert P, Walboomers JM et al. Human papillomavirus DNA and genotypes: prognostic factors for progression of cervical intraepithelial neoplasia. Int J Gynecol Cancer 1994;4:73-8.
6. Kjaer SK, van den Brule AJ, Bock JE et al. Human papillomavirus - the most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer 1996;65:601-6.
7. WHO. Control of cancer of the cervix. A WHO meeting. Bull WHO 1986;64:607-18.
8. Stjernward J, Eddy D, Luthra U, Stanley K. Plotting a new course for cervical cancer screening in the developing countries. World Health Forum 1987;8:42-5.
9. Singh V, Sehgal A, Parashari A, Sodhani P, Satyanarayana L. Early detection of cervical cancer through acetic acid application - an aided visual inspection. Singapore Med J 2001;42:351-4.
10. Sodhani P, Gupta S, Singh V, Halder K, Parashari A. Sensitivity of Pap test to detect high grade lesions: what should be the acceptable cytology threshold for colposcopic referrals. Acta Cytol (in press).
11. Rao L, Kamat V, Boon ME, Valiathan M, Rao ACK. Pap smear quality parameter of 3 sampling devices used by auxillary nurse midwives on symptomatic rural Indian women. Acta Cytol 2005;49:249-56.
12. Parashari A, Singh V, Sehgal A, Satyanaryan L, Sodhani P, Gupta MM. Low cost technology for screening uterine cervical cancer. Bull World Health Organ 2000;78:964-7.
13. The Bethesda System for reporting cervical/vaginal cytological diagnosis. Acta Cytol 1993;37:115-24.
14. Sehgal A, Singh V, Bhambhani S, Luthra UK. Screening for cervical cancer by direct inspection. Lancet 1991;338:282.
15. Singh V, Sehgal A, Luthra UK. Screening for cervical cancer by direct inspection. Br Med J 1992;304:534-5.
16. Sankarnarayanan R, Wesley R, Somanathan T et al. Test characteristics of visual inspection with 4% acetic acid (VIA) and Lugols iodine (VILI) in cervical cancer screening in Kerala. Int J Cancer 2003;106:404-8.
17. Basu P, Sankarnarayanan R, Mandal R et al. Calcutta Cervical Neoplasia Early detection study (CEDS) group. Evaluation of down staging in the detection of cervical neoplasia in Kolkata, India. Int J Cancer 2002;100:92-6.
18. Denny L, Kuhn L, Pollack A, Wright TC Jr. Direct visual inspection for cervical cancer screening: an analysis of factors influencing test performance. Cancer 2002;94:1699-707.
19. University of Zimbabwe/JHPIEGO Cervical Cancer Project. Visual inspection with acetic acid for cervical cancer screening test qualities in a primary care setting. Lancet 1999;353:869-73.
20. Nanda K, McCrory DC, Myers ER et al. Accuracy of Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a symptomatic review. Ann Intern Med 2000;132:810-9.
21. The ASCUS-LSIL Triage (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003;188:1383-92.
22. Lee K-J, Lee J-K, Saw H-S. Can human papillomavirus DNA testing substitute for cytology in the detection of high-grade cervical lesions. Arch Pathol Lab Med 2004;128:298-302.
23. Bhatla N, Mukhopadhya A, Joshi S et al. Visual inspection for cervical cancer screening; Evaluation by doctor versus paramedical worker. Indian J Cancer 2004;4:32-6.